Leszek Lisowski
Consultant / Adviseur bij 4BIO Ventures Management Ltd.
Profiel
Leszek Lisowski founded LogicBio Therapeutics, Inc. in 2014, where he worked as President & Chief Executive Officer.
Dr. Lisowski also currently works at 4BIO Ventures Management Ltd., as Advisor.
Dr. Lisowski also formerly worked at The Salk Institute for Biological Studies, as Director from 2013 to 2015.
Dr. Lisowski received his doctorate degree in 2008 from Cornell University, undergraduate degree in 2001 from the University of Bridgeport, and Masters Business Admin degree in 2015 from the University of California San Diego.
Actieve functies van Leszek Lisowski
| Bedrijven | Functie | Begin |
|---|---|---|
4BIO Ventures Management Ltd.
 4BIO Ventures Management Ltd. Investment ManagersFinance 4BIO Ventures Management Ltd (4bio Capital Partners) is an independent venture capital firm founded in 2014 by Andrey Kozlov. The firm headquartered in London, United Kingdom. | Consultant / Adviseur | - |
Eerdere bekende functies van Leszek Lisowski
| Bedrijven | Functie | Einde |
|---|---|---|
| The Salk Institute for Biological Studies | Directeur/Bestuurslid | 01-10-2015 |
| LOGICBIO THERAPEUTICS, INC. | Algemeen Directeur | - |
Opleiding van Leszek Lisowski
| Cornell University | Doctorate Degree |
| University of California San Diego | Masters Business Admin |
| University of Bridgeport | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 2 |
|---|---|
LogicBio Therapeutics, Inc.
 LogicBio Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology LogicBio Therapeutics, Inc. engages in the development of a genome editing technology platform. It focuses on the commercialization of GeneRide, which enables the site-specific integration of a therapeutic transgene without nucleases or exogenous promoters by harnessing the native process of homologous recombination. Its pipeline includes LB-001, LB-301 and LB-401. The company was founded by Mark A. Kay, Leszek Lisowski, and Adi Barzel in August 2014 and is headquartered in Lexington, MA. | Health Technology |
4BIO Ventures Management Ltd.
4BIO Ventures Management Ltd. Investment ManagersFinance 4BIO Ventures Management Ltd (4bio Capital Partners) is an independent venture capital firm founded in 2014 by Andrey Kozlov. The firm headquartered in London, United Kingdom. | Finance |